2007

EXTRACTA and UFPA, assisted by BIO-RIO Foundation, execute a contract with
PETROBRÁS (Petróleo Brasileiro S.A.) for botanical, biochemical and pharmacological
studies on the coastal area biota in the Amazon River delta. (may 07)

2006

EXTRACTA renews its Cooperation Agreement with Federal University of Pará
(UFPA) for continuation of projects with the Chemistry Department
Extraction Center. (december 06)

EXTRACTA Special Authorization to access Brazilian Genetic Patrimony to expand
its EXTRACTA Bank of Chemical Biodiversity was renewed by Brazilian Government
(CGEN/MMA) for a new biennium. (august 06)

2005

EXTRACTA and INSTITUT DE RÉCHÈRCHE PIERRE FABRE enter into collaboration for
certification and standarlization of plants supplies for phytotherapy. (August 05)

EXTRACTA expands activities into phytotherapic supply quality control in accordance to
the Brazilian Agency for Food and Drug Administration (ANVISA). (August 05)

AVFS buys Solis Biotech Venture participation and becomes holder of 87.5% of
EXTRACTA stock (March 04)

2004

AVFS buys OXITENO venture participation and becomes majority shareholder of Extracta
Moléculas Naturais (December 04)

Work in EXTRACTA-GlaxoSmithKline Collaboration completed (December 04)

EXTRACTA to pursue commercial exploitation of Brazilian Genetic Patrimony (June 04)

EXTRACTA first to receive a Special License from the Brazilian Government to access the country genetic patrimony for commercial endeavors (June 04)

2003

Glaxo and EXTRACTA sign a one year extension on their reseach collaboration contract
(December 03)

New venture investor at EXTRACTA: OXITENO Indústrias Químicas acquires option to buy
1/3 of Company stock (April 03)

2002

EXTRACTA concludes initial phase of Research Collaboration Contract with GlaxoSmithKline:
HTS of the Chemical Biodiversity Bank yields seven natural compounds active on Elastase
(7) and three others against multi-resistant strains of the hospital infection germ
Staphylococcus aureus (August 02)

2001

Genzyme and Extracta establish a Research Collaboration Contract (October 01)

2000

Bank adds value to Brazilian Flora (October 00)

Solis Biotec venture investors buys 38,5% of EXTRACTA stock (October 00)

Biominas Foundation invests in technological expansion of EXTRACTA (July 00)

EXTRACTA, a Bio-Rio Incubator venture matures into a full Corporation and commands
seed money (“Sociedade Anônima”) (July 00)

1999

Brazilian scientists to lead first commercial study of National biodiversity (July 99)

$3m deal launches major hunt for drug leads in Brazil (julho 99)

GlaxoWellcome and EXTRACTA enter into the largest research collaboration deal South
of the Equator (July 99)